News for the Multiple Sclerosis Community

Mylan will distribute Natco's Generic Copaxone in the US

Natco Pharma announced it has signed a licence and supply agreement with US-based Mylan for the global sale of generic version of Teva's patented 'Copaxone', a drug prescribed for multiple sclerosis.

I wonder how soon insurance companies are going to start substituting the generic?